Global Vaccine Contract Manufacturing Market | CAGR 12.11%

The Global Vaccine Contract Manufacturing Market to grow from USD 1,736.09 Million in 2018 to USD 3,865.98 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 12.11%. Some of the major market players include Ajinomoto Althea, Inc., Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, LONZA, and Merck KGaA.

360iResearch Logo
Global Vaccine Contract Manufacturing Market | CAGR 12.11%
Report Code: PH-2AA0DCE | Publishing Date: September 2019 | Number of Pages: 115
Global Vaccine Contract Manufacturing Market | CAGR 12.11%

Company Usability Profiles:

The global vaccine contract manufacturing market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global vaccine contract manufacturing market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Ajinomoto Althea, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • LONZA
  • Merck KGaA
  • Albany Molecular Research, Inc.
  • Catalent, Inc.
  • Cobra Bio
  • ICON plc.
  • IDT Biologika
  • KBI Biopharma
  • Paragon Bioservices, Inc.
  • Pharmaceutical Product Development, LLC
  • PRA Health Sciences

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Vaccine Contract Manufacturing Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY TYPE
    • Attenuated Vaccine
    • DNA Vaccines
    • Inactivated Vaccine
    • Subunit Vaccines
    • Toxoid Vaccines
  • GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY FUNCTION
    • Downstream
      • Analytical & QC studies
      • Fill & Finish Operations
      • Packaging
    • Upstream
      • Bacterial expression systems
      • Baculovirus/insect expression systems
      • Mammalian expression systems
      • Yeast expression systems
  • GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATIONS
    • Human Use
    • Veterinary
  • GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • South Korea
      • Thailand
    • Europe, Middle East & Africa
      • Denmark
      • France
      • Germany
      • Italy
      • Netherlands
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • United Arab Emirates
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Vaccine Contract Manufacturing Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Vaccine Contract Manufacturing Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Vaccine Contract Manufacturing Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Vaccine Contract Manufacturing Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Vaccine Contract Manufacturing Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Vaccine Contract Manufacturing Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Vaccine Contract Manufacturing Market .
  • Evaluate the key vendors in the Global Vaccine Contract Manufacturing Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Market Data Feed
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
        2. Paradigm shift toward cell-based vaccine production
        3. Key advantages such as cost and time saving offered by contract services
        4. Vaccination coverage across the globe
      2. Restraints
        1. Limited outsourcing by well-established vaccine manufacturers
      3. Opportunities
        1. Rising global demand to cater to the growing population of varied age groups.
        2. Innovation and robust vaccine pipeline
      4. Challenges
        1. Pharma companies manufacturing operations in-house to gain strategic control
    3. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Client Customizations
  5. Global Vaccine Contract Manufacturing Market, by Type
    1. Overview
    2. Market Sizing & Forecasting
    3. Attenuated Vaccine
    4. DNA Vaccines
    5. Inactivated Vaccine
    6. Subunit Vaccines
    7. Toxoid Vaccines
  6. Global Vaccine Contract Manufacturing Market, by Function
    1. Overview
    2. Market Sizing & Forecasting
    3. Downstream
      1. Analytical & QC studies
      2. Fill & Finish Operations
      3. Packaging
    4. Upstream
      1. Bacterial expression systems
      2. Baculovirus/insect expression systems
      3. Mammalian expression systems
      4. Yeast expression systems
  7. Global Vaccine Contract Manufacturing Market, by Applications
    1. Overview
    2. Market Sizing & Forecasting
    3. Human Use
    4. Veterinary
  8. Global Vaccine Contract Manufacturing Market, by Geography
    1. Overview
    2. Market Sizing & Forecasting
    3. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Chile
      5. Mexico
      6. United States
    4. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    5. Europe, Middle East & Africa
      1. Denmark
      2. France
      3. Germany
      4. Italy
      5. Netherlands
      6. Qatar
      7. Russia
      8. Saudi Arabia
      9. South Africa
      10. Spain
      11. United Arab Emirates
      12. United Kingdom
  9. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
        1. Forefront
        2. Pathfinders
        3. Niche
        4. Vital
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  10. Company Usability Profiles
    1. Ajinomoto Althea, Inc.
      1. Overview
      2. Strategy
      3. SWOT
    2. Cytovance Biologics
      1. Overview
      2. Strategy
      3. SWOT
    3. FUJIFILM Diosynth Biotechnologies
      1. Overview
      2. Strategy
      3. SWOT
    4. LONZA
      1. Overview
      2. Strategy
      3. SWOT
    5. Merck KGaA
      1. Overview
      2. Strategy
      3. SWOT
    6. Albany Molecular Research, Inc.
    7. Catalent, Inc.
    8. Cobra Bio
    9. ICON plc.
    10. IDT Biologika
    11. KBI Biopharma
    12. PRA Health Sciences
    13. Paragon Bioservices, Inc.
    14. Pharmaceutical Product Development, LLC
  11. Appendix
    1. Discussion Guide
    2. Author Details

List of Tables

  1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS/INSECT EXPRESSION SYSTEMS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  17. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  20. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  21. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  22. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  23. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  24. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  25. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  26. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  27. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  28. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  29. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  30. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  31. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  32. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  33. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  34. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  35. CHILE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  36. CHILE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  37. CHILE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  38. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  39. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  40. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  41. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  42. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  43. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  44. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  45. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  46. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  47. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  48. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  49. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  50. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  51. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  52. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  53. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  54. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  55. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  56. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  57. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  58. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  59. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  60. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  61. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  62. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  63. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  64. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  65. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  66. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  67. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  68. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  69. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  70. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  71. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  72. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  73. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  74. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  75. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  76. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  77. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  78. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  79. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  80. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  81. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  82. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  83. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  84. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  85. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  86. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  87. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  88. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  89. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  90. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  91. NETHERLANDS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  92. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  93. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  94. QATAR VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  95. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  96. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  97. RUSSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  98. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  99. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  100. SAUDI ARABIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  101. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  102. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  103. SOUTH AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  104. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  105. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  106. SPAIN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  107. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  108. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  109. UNITED ARAB EMIRATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  110. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  111. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2016-2025 (USD MILLION)
  112. UNITED KINGDOM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2016-2025 (USD MILLION)
  113. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RANKING
  114. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: AUTHOR DETAILS

List of Figures

  1. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
  2. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: RESEARCH FRAMEWORK
  3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: FORECASTING METHODOLOGY
  4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MARKET CONNECTIVITY
  6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
  7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: PORTERS FIVE FORCES ANALYSIS
  8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018 VS 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2025 (USD MILLION)
  10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2025 (USD MILLION)
  12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2018 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATIONS, 2025 (USD MILLION)
  14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
  17. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY NEWS TYPE
  18. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY COMPANY
  19. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY YEAR
  1. Ajinomoto Althea, Inc.
  2. Cytovance Biologics
  3. FUJIFILM Diosynth Biotechnologies
  4. LONZA
  5. Merck KGaA
  6. Albany Molecular Research, Inc.
  7. Catalent, Inc.
  8. Cobra Bio
  9. ICON plc.
  10. IDT Biologika
  11. KBI Biopharma
  12. Paragon Bioservices, Inc.
  13. Pharmaceutical Product Development, LLC
  14. PRA Health Sciences
Global Vaccine Contract Manufacturing Market
Report Code
PH-2AA0DCE
Publishing Date
September 2019
Number of Pages
115
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $5449
CORPORATE USER LICENSE $4449
SINGLE USER LICENSE $3449
WEB PACK LICENSE $2949
DATA PACK LICENSE $1749

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.